Easton Operating Income from 2010 to 2026
Easton Pharmaceutica's Operating Income is increasing with stable movements from year to year. Operating Income is predicted to flatten to about -227.7 K. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Easton Pharmaceutica generates from its operations. View All Fundamentals
Check out the analysis of Easton Pharmaceutica Correlation against competitors. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
Operating Income | First Reported 2010-12-31 | Previous Quarter -216.8 K | Current Value -227.7 K | Quarterly Volatility 151.9 K |
Check Easton Pharmaceutica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Easton Pharmaceutica's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 161.2 K or Research Development of 179.8 K, as well as many indicators such as Price To Sales Ratio of 0.94, Dividend Yield of 0.0 or PTB Ratio of 0.13. Easton financial statements analysis is a perfect complement when working with Easton Pharmaceutica Valuation or Volatility modules.
Easton | Operating Income | Build AI portfolio with Easton Stock |
Latest Easton Pharmaceutica's Operating Income Growth Pattern
Below is the plot of the Operating Income of Easton Pharmaceutica over the last few years. Operating Income is the amount of profit realized from Easton Pharmaceutica operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Easton Pharmaceutica is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Easton Pharmaceutica's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Easton Pharmaceutica's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Easton Operating Income Regression Statistics
| Arithmetic Mean | (225,147) | |
| Geometric Mean | 197,857 | |
| Coefficient Of Variation | (67.45) | |
| Mean Deviation | 100,776 | |
| Median | (188,542) | |
| Standard Deviation | 151,857 | |
| Sample Variance | 23.1B | |
| Range | 690.6K | |
| R-Value | 0.16 | |
| Mean Square Error | 24B | |
| R-Squared | 0.02 | |
| Significance | 0.55 | |
| Slope | 4,665 | |
| Total Sum of Squares | 369B |
Easton Operating Income History
About Easton Pharmaceutica Financial Statements
Investors use fundamental indicators, such as Easton Pharmaceutica's Operating Income, to determine how well the company is positioned to perform in the future. Although Easton Pharmaceutica's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Operating Income | -216.8 K | -227.7 K |
Currently Active Assets on Macroaxis
When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock:Check out the analysis of Easton Pharmaceutica Correlation against competitors. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.